| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 139 |
| 1 | ONASEMNOGENE ABEPARVOVEC-XIOI | 136 |
| 2 | ASPIRIN 325 MG | 131 |
| 3 | ASPIRIN 81 MG | 131 |
| 4 | CLOZAPINE | 121 |
| 5 | FUROSEMIDE | 110 |
| 6 | PREDNISOLONE | 98 |
| 7 | PREDNISOLONE ORAL | 98 |
| 8 | PREDNISOLONE ORAL SOLUTION | 98 |
| 9 | CYCLOPHOSPHAMIDE | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 136 | 0.0589 |
| 1 | CLOZAPINE | 121 | 0.0010 |
| 2 | FLUOROURACIL | 62 | 0.0008 |
| 3 | FLUOROURACIL CREAM, 0.5% | 61 | 0.0008 |
| 4 | DOXORUBICIN | 68 | 0.0008 |
| 5 | OLANZAPINE | 47 | 0.0007 |
| 6 | DOCETAXEL ANHYDROUS | 44 | 0.0006 |
| 7 | DOCETAXEL | 44 | 0.0006 |
| 8 | TRASTUZUMAB | 40 | 0.0006 |
| 9 | PREDNISOLONE ORAL SOLUTION | 98 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 242 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 229 |
| 2 | Atypical Antipsychotic [EPC] | 172 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 143 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 140 |
| 5 | Benzodiazepine [EPC] | 136 |
| 6 | Loop Diuretic [EPC] | 120 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 115 |
| 8 | Proton Pump Inhibitor [EPC] | 113 |
| 9 | Platinum-based Drug [EPC] | 92 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 18 | 0.0031 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 8 | 0.0021 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 143 | 0.0015 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 6 | 0.0014 |
| 4 | Provitamin D2 Compound [EPC] | 41 | 0.0014 |
| 5 | Antisense Oligonucleotide [EPC] | 15 | 0.0013 |
| 6 | Lipid Emulsion [EPC] | 3 | 0.0011 |
| 7 | Benzothiazole [EPC] | 2 | 0.0009 |
| 8 | Carnitine Analog [EPC] | 3 | 0.0008 |
| 9 | Typical Antipsychotic [EPC] | 20 | 0.0008 |